Standout Papers

Efficacy and Safety of 5-Day Oral Ensitrelvir for Patients With Mild to Moderate COVID-19 2024 202635
  1. Efficacy and Safety of 5-Day Oral Ensitrelvir for Patients With Mild to Moderate COVID-19 (2024)
    Hiroshi Yotsuyanagi, Norio Ohmagari et al. JAMA Network Open

Immediate Impact

1 by Nobel laureates 83 standout
Sub-graph 1 of 23

Citing Papers

Adipokines: masterminds of metabolic inflammation
2024 Standout
Long COVID science, research and policy
2024 Standout
2 intermediate papers

Works of Bong Ki being referenced

Efficacy and Safety of 5-Day Oral Ensitrelvir for Patients With Mild to Moderate COVID-19
2024 Standout
The Frequency and Risk Factors of Colorectal Adenoma in Health-Check-up Subjects in South Korea: Relationship to Abdominal Obesity and Age
2010

Author Peers

Author Last Decade Papers Cites
Bong Ki 59 127 39 119 16 292
Bingcheng Feng 46 90 14 119 13 270
Joseph T. Krill 90 108 35 154 11 304
Roberto Prizont 91 80 28 83 18 317
Juan Zeng 55 112 26 113 17 258
Chinmay Dwibedi 33 82 16 175 8 268
Xiali Qin 39 61 40 205 13 312
Giovanna Vitale 129 144 32 73 19 332
W.S. Harmsen 146 88 23 101 10 263
Yudong Jiang 56 85 18 116 14 286
Shreya Celly 93 155 32 169 15 297

All Works

Loading papers...

Rankless by CCL
2026